Finlande < France < Grèce

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 152.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000024 (2012)	A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]	Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
000038 (2016)	Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]	Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
000049 (2012)	Hubert De Boysson [France] ; Jérome Février [France] ; Amélie Nicolle [France] ; Christophe Auzary [France] ; Loïk Geffray [France]	Tocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
000054 (2016)	Stanislas Faguer [France] ; François Vergez [France] ; Michael Peres [France] ; Inès Ferrandiz [France] ; Audrey Casemayou [France] ; Julie Belliere [France] ; Olivier Cointault [France] ; Laurence Lavayssiere [France] ; Marie-Béatrice Nogier [France] ; Grégoire Prevot [France] ; Antoine Huart [France] ; Christian Recher [France] ; Lionel Rostaing [France]	Tocilizumab added to conventional therapy reverses both the cytokine profile and CD8+Granzyme+ T‐cells/NK cells expansion in refractory hemophagocytic lymphohistiocytosis
000064 (2010)	S. Laurent ; J. Le Parc ; T. Clérici ; M. Bréban ; E. Mahé [France]	Onset of psoriasis following treatment with tocilizumab
000070 (2016)	Janet S. Lee [États-Unis] ; M. John Chapman [France] ; Paolo Piraino [Italie] ; Jens Lamerz [Suisse] ; Thomas Schindler [Suisse] ; Paul Cutler [Suisse] ; Gregor Dernick [Suisse]	Remodeling of plasma lipoproteins in patients with rheumatoid arthritis: Interleukin‐6 receptor‐alpha inhibition with tocilizumab
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000131 (2010)	J. J. Leyden [États-Unis] ; H. Gollnick [Allemagne] ; D. Thiboutot [États-Unis] ; B. Dreno [France] ; V. Bettoli [Italie] ; S. Kang [États-Unis] ; A. Shalita [États-Unis] ; V. Torres	The hypothetical role of FoxO1 in acne is interesting, but more study is needed before any conclusions can be drawn
000143 (2012)	Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]	Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
000192 (2009)	Guillaume Moulis [France] ; Laurent Sailler [France] ; Leonardo Astudillo [France] ; Philippe Arlet [France]	Abatacept for relapsing polychondritis
000246 (2011)	Bernard Bannwarth [France]	Prise en charge thérapeutique de l’inflammation d’origine rhumatismale
000250 (2009)	Luca Semerano [France] ; Marie-Christophe Boissier [France]	Les anticorps monoclonaux dans les maladies immunes inflammatoires chroniques
000278 (2013)	Frédéric Perros [France] ; Marc Humbert [France] ; Sylvia Cohen-Kaminsky [France]	Hypertension artérielle pulmonaire
000299 (2011)	Nada Kherbeck [France] ; Mathieu C. Tamby [France] ; Guillaume Bussone [France] ; Hanadi Dib [France] ; Frederic Perros [France] ; Marc Humbert [France] ; Luc Mouthon [France]	The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension
000335 (2016)	Anais Gardette [France] ; Sébastien Ottaviani [France] ; Jérémie Sellam [France] ; Francis Berenbaum [France] ; Frédéric Lioté [France] ; Bruno Fautrel [France] ; Elisabeth Palazzo [France] ; Alain Meyer [France] ; Jean Sibilia [France] ; Philippe Dieudé [France]	Body mass index and response to abatacept in rheumatoid arthritis
000337 (2011)	Sylvie Fabre [France]	Approches pharmacologiques en immuno-rhumatologie
000347 (2013)	Monika M. Schoels [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho M. Murikama [Japon] ; Norihiro Nishimoto [Japon] ; Josef S. Smolen [Autriche]	Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement
000348 (2013)	Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas]	Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)
000355 (2011)	Pascale Louis-Plence [France] ; Yves-Marie Pers [France] ; Pierre Portales [France] ; Julie Quentin [France] ; Sylvie Fabre [France] ; Jean-François Eliaou [France] ; Christian Jorgensen [France]	Longitudinal immunomonitoring following tocilizumab in rheumatoid arthritis
000365 (2013)	M. Kostine ; T. Barnetche ; E. Ardouin ; M. Joly [France] ; E. Rabois [France] ; B. Glace [France] ; T. Schaeverbeke ; C. Richez	FRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis?
000368 (2012)	Vivian P. Bykerk [États-Unis, Canada] ; Andrew J K. Östör [Royaume-Uni] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Winfried Graninger [Autriche] ; William Bensen [Canada] ; Michael T. Nurmohamed [Pays-Bas] ; Andreas Krause [Allemagne] ; Corrado Bernasconi [Suisse] ; Andrea Stancati [Suisse] ; Jean Sibilia [France]	Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practice

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i -k "France" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AffPays.i  \
                -Sk "France" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AffPays.i
   |clé=    France
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021